ARTICLES OF THE ADHESION GPCR CONSORTIUM
In light of the discovery of Adhesion GPCRs as separate class of GPCRs and the growing research in the field of Adhesion GPCRs, it appears timely to capitalize on these recent developments and to provide the interested researchers with a stable forum for the discussion and evaluation of the latest breakthroughs in Adhesion GPCRs biology.
I. AIM, LOCATION, AND OBJECTIVES
The “Adhesion GPCR Consortium” is an international association with scientific goals.
The specific aim of the Adhesion GPCR Consortium is the promotion of scientific knowledge concerning the structure and function of Adhesion GPCRs, as well as the dissemination of scientific knowledge.
The primary activity of the Adhesion GPCR Consortium is the preparation of regular meetings.
The Adhesion GPCR Consortium maintains a website at www.adhesiongpcr.org for the display of relevant announcements and links to the Adhesion GPCR Consortium meetings, as well as to other activities relevant to research, training, and education directed at Adhesion GPCRs.
The Adhesion GPCR Consortium carries out actions directly or indirectly pertaining to its objective, primarily via the organization of or participation in congresses, conferences, and presentations, as well as the publication of books, periodicals, and other media.
The office of the association shall be situated in The Netherlands, Department of Experimental Immunology, Academic Medical Center, Meibergdreef 9, 1105 AZ in Amsterdam. The office may be transferred by resolution of the Board of the association. If deemed appropriate, the Board may also establish one or more administrative offices.
The organization shall be entitled to carry out any actions directly or indirectly pertaining to its objective, including the acquisition, rental or borrowing of property, offices, installations, and other facilities, the organization of or participation in congresses, conferences, and presentations, and the publishing of books, periodicals, and other publications. It shall be entitled at all times to call upon outside experts in so far as it considers this useful on scientific or practical grounds.
The association consists of ordinary members and of supporting members. Admission to membership is open to private individuals and corporate entities of any nationality.
All those persons are accepted as ordinary members by a resolution of the Board of the Consortium, on condition that the member takes an interest in the activities organized by the Consortium.
Ordinary members can be either regular or associated members, with the understanding that individual laboratories may have only one regular member.
All private individuals or corporate entities (in addition to business, non-profit organizations, scientific institutions, etc.), which, without becoming ordinary members, wish to support the Consortium by financial means may be accepted as supporting member.
There is (and will be) no fee for membership to the Adhesion GPCR Consortium.
All members shall be free to withdraw from the Consortium at all times on the condition that they inform the Board in writing of their intention to do so.
III. GENERAL ASSEMBLY
The General Assembly possesses full power in order to realize the objectives of the Consortium.
It consists of all ordinary and supporting members. It is charted by one of the Chairpersons of the Board of the Consortium. The powers of the General Assembly are as follows:
- to appoint and remove from office the members of the Board of the Consortium;
- to amend the articles of the Statutes of the Consortium;
- to improve and expand the organization of the Consortium.
The General Assembly meets in full rights at least once in two years. A convening letter from the Chairpersons of the Board of the Consortium will inform of the scheduled dates, location and agenda. In special cases, a special General Assembly can be called by any of the Chairpersons.
All regular members shall have equal voting rights at the General Assembly. Associated members have no voting rights. Resolutions shall be passed by a simple majority of the votes present or represented. No valid decision may be taken on any matter not mentioned in the agenda.
The General Assembly’s resolutions shall be entered in a regular register of minutes signed by the Chairpersons and at least one member of the Board.
IV. MODIFICATIONS OF THE STATUTES – DISSOLUTION
Any proposition whose object is a modification of the Statutes or dissolution of the Consortium must come from the Board or at least two-thirds of the members of the Consortium.
The Consortium shall be run by a Board consisting of no less than three members.
The Board of the Consortium is appointed and approved by the General Assembly.
The Board of the Consortium shall appoint from among its members Chairpersons, of which one acts as Secretary-treasurer. If a Chairperson is unable to attend, his or her duties shall be taken over by the oldest Board member present.
The Board of the Consortium shall meet as convened by the Chairpersons of the Board.
The Board of the Consortium shall have full powers to manage and administer the Consortium with the exception of those powers explicitly reserved for the General Assembly. The Chairpersons of the Board take responsibility for organization of the regular meetings of the Consortium.
The decisions of the Board of the Consortium are taken by an absolute majority of votes. In the event of a tied vote, the Chairpersons shall have the casting vote. The decisions of the Board of the Consortium shall be entered in a special register, which shall be signed by the Chairpersons. It shall be kept at the office of the Consortium and shall be available for consultation by members.
VI. BUDGETS AND ACCOUNTS
The organization’s financial year starts on January 1st and ends on December 31st.
- Jörg Hamann (NL)
- Tobias Langenhan (DE)
- Kelly Monk (USA)
- Xianhua Piao (USA)
- Demet Araç (USA)
- Gabriela Aust (DE)
- Randy Hall (USA)
- Hsi-Hsien Lin (TW)
- Helgi Schiöth (SE)
- Torsten Schöneberg (DE)
- Yuri Ushkaryov (UK)